Efficacy of linagliptin on cardiovascular risk and cardiometabolic parameters in Thai patients with type 2 diabetes mellitus: A real-world observational study-Reference-Cited by-同舟云学术

Efficacy of linagliptin on cardiovascular risk and cardiometabolic parameters in Thai patients with type 2 diabetes mellitus: A real-world observational study

Published:2022-05 Issue:5 Volume:16 Page:102498
ISSN:1871-4021
Container-title:Diabetes & Metabolic Syndrome: Clinical Research & Reviews
language:en
Short-container-title:Diabetes & Metabolic Syndrome: Clinical Research & Reviews

Author:

Poonchuay Natnicha,Wattana Konkanok,Uitrakul Suriyon^ORCID

Publisher

Elsevier BV

Subject

General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference24 articles.

1. IDF diabetes atlas,2019

2. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies;Huxley;BMJ,2006

3. Mortality and causes of death in the WHO multinational study of vascular disease in diabetes;Morrish;Diabetologia,2001

4. SAVOR-TIMI 53 Steering Committee and Investigators. Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus;Scirica;N Engl J Med,2013

5. Alogliptin after acute coronary syndrome in patients with type 2 diabetes;White;N Engl J Med,2013

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging role of antidiabetic drugs in cardiorenal protection;Frontiers in Pharmacology;2024-02-06

2. Factors Correlated to the Renoprotective Effect of Sitagliptin in Patients with Type 2 Diabetes Mellitus: Retrospective Observational Study;Advances in Pharmacological and Pharmaceutical Sciences;2024-01

3. Evaluation of linagliptin and insulin combined therapy on unfolded protein response in type 1 diabetic mouse heart;Chemical Biology & Drug Design;2023-08-02

4. Renoprotective Effect of Thai Patients with Type 2 Diabetes Mellitus Treated with SGLT-2 Inhibitors versus DPP-4 Inhibitors: A Real-World Observational Study;Advances in Pharmacological and Pharmaceutical Sciences;2023-05-15